Skip to content

Popliteal Artery Entrapment Syndrome & TRanscutaneoUS Oxymetry

Application de l'oxymétrie Dynamique Pour le Diagnostic Des pièges artériels poplités

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03356379
Acronym
PETRUS
Enrollment
60
Registered
2017-11-29
Start date
2017-11-22
Completion date
2019-11-15
Last updated
2019-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Popliteal Entrapment Syndrome

Keywords

Diagnosis, Peripheral artery disease, sports

Brief summary

Aim of the study is to test the feasibility of transcutaneous oxygen pressure (TcPO2) recording in the diagnosis of popliteal entrapment syndrome (PES) in 30 patients with suspected PES and 30 asymptomatic control heathy subjects

Detailed description

Patients suspected of PES and healthy cpontrols after detailled explanation of the protocol will have a recording of tcpO2 on both calves and will perform a series of elevation on foot in the standing position.

Interventions

Measurement of TcpO2 on calves and chests. Calculation of the DROP index (decrease from rest of oxygen pressure)on both calves

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Intervention model description

transcutaneous oximetry

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age over 18 years * Insurance company alffiliation Symptoms consistent with PES (patients) or absence of symptoms (controls)

Exclusion criteria

* Refuse to participate Exclusion period from another protocole

Design outcomes

Primary

MeasureTime frameDescription
Presence of a significant DROP decrease1 hourComparison of DROP value between PES patients and controls

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026